What is the use of oral Clotrimazole (antifungal medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Oral clotrimazole is recommended for mild oropharyngeal candidiasis at a dosage of 10 mg 5 times daily for 7-14 days. This recommendation is based on the most recent and highest quality study available, which is the 2016 update by the Infectious Diseases Society of America 1. The study suggests that clotrimazole troches, 10 mg 5 times daily, are a recommended treatment for mild disease, with a strong recommendation and high-quality evidence.

Key Points to Consider

  • The dosage and duration of treatment should be individualized based on the severity of the infection and the patient's response to therapy.
  • Patients should be advised to avoid eating or drinking for 30 minutes after using the medication to maximize contact time with infected tissues.
  • Common side effects of oral clotrimazole include nausea, vomiting, or unpleasant taste, and the medication may not be suitable for patients with liver disease or those taking certain medications that interact with azole antifungals.
  • For moderate to severe disease, oral fluconazole at a dosage of 100-200 mg daily for 7-14 days is recommended, as stated in the 2016 update 1.
  • The 2016 update also recommends itraconazole solution or posaconazole suspension for fluconazole-refractory disease, with a strong recommendation and moderate-quality evidence 1.

Important Considerations

  • The patient's immune status and overall health should be taken into account when selecting a treatment regimen.
  • The potential for drug interactions and the patient's medical history should be carefully evaluated before initiating therapy.
  • The patient should be monitored for signs of treatment failure or adverse effects, and the treatment regimen should be adjusted as needed.
  • As stated in the 2009 update, chronic suppressive therapy is usually unnecessary for patients with HIV infection, but if required, fluconazole at a dosage of 100 mg 3 times weekly is recommended 1.

From the FDA Drug Label

CLINICAL PHARMACOLOGY Clotrimazole is a broad-spectrum antifungal agent that inhibits the growth of pathogenic yeasts by altering the permeability of cell membranes. After oral administration of a 10 mg clotrimazole troche to healthy volunteers, concentrations sufficient to inhibit most species of Candida persist in saliva for up to three hours following the approximately 30 minutes needed for a troche to dissolve The long term persistence of drug in saliva appears to be related to the slow release of clotrimazole from the oral mucosa to which the drug is apparently bound Repetitive dosing at three hour intervals maintains salivary levels above the minimum inhibitory concentrations of most strains of Candida; In another study, the mean serum concentrations were 4.98 ± 3.7 and 3.23 ± 1. 4 nanograms/mL of clotrimazole at 30 and 60 minutes, respectively, after administration as a troche.

Oral Clotrimazole is used as an antifungal agent.

  • The drug is administered orally in the form of a troche, which is a large, slowly dissolving tablet (lozenge) containing 10 mg of clotrimazole.
  • Key Points:
    • Concentrations of clotrimazole sufficient to inhibit most species of Candida persist in saliva for up to three hours after administration.
    • Repetitive dosing at three hour intervals maintains salivary levels above the minimum inhibitory concentrations of most strains of Candida.
    • Mean serum concentrations of clotrimazole were measured in a study, with levels of 4.98 ± 3.7 and 3.23 ± 1.4 nanograms/mL at 30 and 60 minutes, respectively, after administration as a troche 2.

From the Research

Oral Clotrimazole

  • Oral clotrimazole is used to treat oral candidiasis, also known as thrush, in patients with HIV infection 3, 4, 5, 6, 7.
  • Clotrimazole troches are a common treatment for thrush in patients with HIV infection, and have been shown to be effective in treating the condition 3, 4, 5.
  • However, studies have shown that fluconazole is more effective than clotrimazole in eradicating Candida from the oral flora and providing a more prolonged disease-free state 3, 4, 5.
  • Clotrimazole has been found to be just as effective as fluconazole for resolution of clinical symptoms, except when patient compliance is poor 6.
  • The use of clotrimazole troches has been compared to fluconazole in several studies, with fluconazole being shown to be more effective in preventing fungal infections, including cryptococcosis and esophageal candidiasis 7.
  • The dosage of clotrimazole troches is typically 10 mg taken five times daily 3, 4, 5, 7.
  • Side effects of clotrimazole troches are generally mild, but can include liver enzyme elevations and other adverse effects 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 1992

Research

A systematic review of the management of oral candidiasis associated with HIV/AIDS.

SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.